Profile data is unavailable for this security.
About the company
Namwiwat Medical Corporation Public Company Limited is a Thailand-based company, which is engaged in the core business relating to manufacturing and distribution of medical equipment autoclave, rental of medical equipment and rendering medical services. Its segments include medical equipment manufacturing and distribution, medical supplies manufacturing and distribution, and CSSD disinfection medical equipment maintenance services segment and waste services. The Company’s products and services cleaning and sterilizing medical instruments, disinfecting the air and surfaces, treatment of medical infectious waste, software product group for data management, medical furniture product group, medical materials and supplies group, sterilization indicator material group, and medical cleaning product group. The Company has a customer base of more than 1,200 hospitals and public health organizations covering both domestic and international markets.
- Revenue in THB (TTM)1.79bn
- Net income in THB131.25m
- Incorporated1992
- Employees457.00
- LocationNamwiwat Medical Corp PCLNai Khlong Bang Pla Kod Subdistrict PhraBANGKOK 10290ThailandTHA
- Phone+66 24617287
- Fax+66 24617291
- Websitehttps://namwiwat.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Austco Healthcare Ltd | 1.79bn | 130.38m | 2.59bn | 174.00 | 19.68 | 2.22 | 13.42 | 1.45 | 0.016 | 0.016 | 0.2197 | 0.1421 | 1.02 | 3.91 | 4.67 | -- | 7.43 | 9.35 | 10.83 | 13.33 | 52.05 | 53.07 | 7.29 | 8.39 | 1.28 | -- | 0.1233 | -- | 39.98 | 19.76 | -16.15 | 18.83 | 25.65 | -- |
| Business Alignment PCL | 2.13bn | 327.24m | 2.61bn | 31.00 | 7.97 | 2.83 | 7.52 | 1.23 | 0.5447 | 0.5447 | 3.54 | 1.53 | 1.16 | 4.31 | 4.81 | 68,624,310.00 | 17.84 | 12.03 | 30.33 | 20.61 | 23.76 | 20.63 | 15.40 | 12.12 | 1.40 | 148.92 | 0.2666 | 82.24 | 1.49 | 18.80 | 11.44 | 19.64 | -48.87 | 16.00 |
| Vincent Medical Holdings Ltd | 3.46bn | 347.75m | 2.65bn | 1.46k | 7.43 | 1.06 | 5.14 | 0.7656 | 0.136 | 0.136 | 1.35 | 0.9542 | 0.9226 | 3.30 | 3.96 | 654,893.10 | 9.72 | 10.32 | 13.97 | 14.95 | 34.47 | 34.77 | 10.53 | 10.25 | 1.55 | -- | 0.2049 | 37.10 | 11.56 | 9.79 | 20.76 | 43.10 | 26.32 | 24.57 |
| Japan Medical Dynamic Marketing Inc | 5.00bn | -214.34m | 2.65bn | 538.00 | -- | 0.5171 | 24.17 | 0.5309 | -40.02 | -40.02 | 933.26 | 953.32 | 0.7202 | 0.6368 | 4.34 | 45,695,190.00 | -3.13 | 4.27 | -3.80 | 4.94 | 59.93 | 65.20 | -4.35 | 5.78 | 1.28 | 12.48 | 0.1802 | 28.50 | 8.35 | 6.79 | -136.31 | -- | -1.37 | 8.45 |
| DVx Inc | 11.25bn | 62.80m | 2.68bn | 334.00 | 41.54 | 1.47 | 12.21 | 0.2385 | 29.46 | 29.46 | 5,278.63 | 831.73 | 2.24 | 17.68 | 4.12 | 165,663,400.00 | 1.25 | 2.64 | 3.28 | 6.45 | 9.60 | 11.08 | 0.558 | 1.28 | 1.23 | -- | 0.0025 | 63.09 | 9.75 | 2.42 | 137.18 | -12.33 | -2.43 | 15.81 |
| Namwiwat Medical Corp PCL | 1.79bn | 131.25m | 2.69bn | 457.00 | 20.48 | 1.32 | 12.48 | 1.51 | 0.1875 | 0.1875 | 2.55 | 2.91 | 0.644 | 2.04 | 3.19 | 3,906,843.00 | 5.70 | 11.20 | 7.29 | 14.80 | 31.32 | 40.63 | 8.85 | 17.03 | 2.04 | 15.67 | 0.197 | -- | 1.24 | 13.09 | -9.90 | 41.50 | -- | -- |
| OLBA Healthcare Holdings Inc | 25.32bn | 290.61m | 2.69bn | 1.39k | 8.77 | 1.05 | 6.33 | 0.1062 | 241.07 | 241.07 | 21,003.79 | 2,008.32 | 2.77 | 16.23 | 4.80 | 89,362,800.00 | 3.17 | 3.43 | 9.91 | 11.39 | 11.26 | 11.49 | 1.15 | 1.22 | 0.9582 | 66.63 | 0.2255 | 30.51 | 3.49 | 2.61 | -4.68 | 34.38 | 28.71 | 14.87 |
| A Plus Biotechnology Co Ltd | 815.90m | 169.54m | 2.84bn | -- | 15.36 | 2.29 | 14.48 | 3.48 | 5.40 | 5.40 | 25.93 | 36.22 | 0.6253 | 0.8183 | 6,551.74 | -- | 13.00 | 5.52 | 14.85 | 6.55 | 69.53 | 65.49 | 20.79 | 9.74 | 4.42 | -- | 0.0735 | 75.94 | 14.01 | 10.18 | 384.79 | 37.11 | 8.86 | -- |
| Holder | Shares | % Held |
|---|---|---|
| JPMorgan Asset Management (Singapore) Ltd.as of 30 Sep 2025 | 4.00m | 0.57% |
